Programmable transdermal therapeutic apparatus

• US 6,539,250 B1
• Filed: 12/15/1999
• Issued: 03/25/2003
• Est. Priority Date: 12/15/1999
• Status: Expired due to Term

• Current Assignee: David S. Bettinger
• Original Assignee: David S. Bettinger
• Inventors: Bettinger, David S.
• Primary Examiner(s): Casler, Brian L.
• Assistant Examiner(s): MAYNARD, JENNIFER J
• Application Number:
  US09/461,305
• Time in Patent Office: 1,196 Days
• Field of Search: 604/590.1, 604/19, 604/20, 604/500, 604/21, 604/501, 604/22, 604/289, 604/290, 604/65-67, 604/246, 604/151, 604/131, 604/30, 604/31, 607/115, 607/149, 700/231, 700/240, 340/286.07
• US Class Current: 604/20
• CPC Class Codes: A61N 1/30 Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Abstract

A programmable transdermal therapeutic apparatus provides facile programming instruction means to query for a patient'"'"'s attributes and to translate these attributes into customized patient limits and instructions of specific medication delivery regimens. More specifically, when the therapeutic apparatus is inserted into an active personal computer and the programming instruction means is uploaded, then the delivery regimen is downloaded into the dispensing device of the therapeutic apparatus. In its preferred embodiment, this transdermal therapeutic apparatus is configured as a floppy disk for its interactions with a personal computer.

Claims

1. A programmable therapeutic apparatus comprising

a) a microprocessor controlled medication dispensing transdermal device, including a patch, communicating by detachable means with

b) a carrier unit communicating by detachable means with

c) a removable computer interface module containing and storing for upload to and activation within a personal computing device a program comprising

a first program component selected to be descriptive of a multiplicity of beneficial therapeutic regimens of at least one medication contained within and actively disposed within said transdermal device,

a second program component selected to query for an individual patient'"'"'s attributes

a third program component selected to translate said patient'"'"'s attributes into customized limits and instructions of a specific beneficial therapeutic regimen compatible with said attributes, and

a fourth program component selected to download said regimen to

d) said carrier unit possessing means for programming of said transdermal device so as to dispense said regimen as an independent entity after programming completion, detachment or said patch from said carrier unit, and application.

2. The programmable therapeutic apparatus of claim 1, wherein said transdermal device possesses a protective storage shield selected to activate said beneficial therapeutic regimen upon removal from said transdermal device.

3. The programmable therapeutic apparatus of claim 1, wherein said transdermal device is selected to deactivate upon the expiration date of said at least one medication and the completion of said specific beneficial therapeutic regimen.

4. The programmable therapeutic apparatus of claim 1, wherein said program possesses a fourth program component selected to possess the ability to query after upload said personal computing device for the time and location.

5. The programmable therapeutic apparatus of claim 1, wherein said program possesses a fifth program component selected to query after upload the original equipment manufacturer internet site for the most current programming instructions and application data.

6. The programmable therapeutic apparatus of claim 1, wherein said program possesses a sixth program component selected to query after upload the pharmaceutical manufacturer internet site for the most current information concerning said medication contained and actively disposed within said transdermal device.

7. The programmable therapeutic apparatus of claim 1, wherein said carrier unit possesses a touchpad and a display for entering and exhibiting alphanumeric data.

8. The method of programming and application of a programmable therapeutic apparatus comprising the steps ofbooting up a personal computer;

2) inserting and connecting a removable computer interface module communicating by detachable means with a carrier unit communicating by detachable means and conveying a microprocessor controlled medication device;

3) permitting and commanding said personal computer to recognize the presence of, upload and activate a program stored on said removable computer interface module;

4) permitting and commanding said program to query the healthcare professional, said personal computer, and the internet for patient, time, current dispenser, and current pharmaceutical data;

5) permitting said program to interpret said data, and select a specific beneficial therapeutic regimen compatible with said data;

6) permitting said program to download said specific beneficial therapeutic regimen to means for programming of said microprocessor controlled medication dispensing device;

7) permitting said program to record and store said pharmaceutical data within said personal computer;

8) permitting said personal computer to close said program;

9) removing said programmable therapeutic apparatus from said personal computer and detaching said removable computer interface module from said carrier unit;

10) detaching said microprocessor controlled medication dispensing device from said carrier unit;

11) removing a protective storage shield from said microprocessor controlled medication dispensing device thereby activating said microprocessor controlled medication dispensing device and attaching said microprocessor controlled medication dispensing device to the patient;

12) permitting said microprocessor controlled medication dispensing device to follow said specific beneficial therapeutic regimen for dispensing to said patient of at least one medication; and

13) removing said microprocessor controlled medication dispensing device from said patient at completion of said specific beneficial therapeutic regimen.